Best AI Index Fund to Buy
Over the last two years, companies with a focus on…
Sell
17
MAZE Quote, Financials, Valuation and Earnings
Last price:
$9.87
Seasonality move
:
--
Day range:
$9.73 - $12.05
52-week range:
$6.71 - $17.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
147.2K
Avg. volume:
159.1K
1-year change:
--
Market cap:
$427M
Revenue:
--
EPS (TTM):
--
MAZE Analysts' Consensus Rating
The 3 analysts providing 12-month price projections for Maze Therapeutics shares anticipate an average target of $25.00, ranging from a low estimate of $19.00 to a high estimate of $28.00. This average target implies a growth of 150.75% compared to the current stock price of $9.97.
Consensus Price Target
$25.00
Highest Price Target
$28.00
Lowest Price Target
$19.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 0 | 3 | 3 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Consensus | -- | Buy | Buy |
MAZE Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
